| Literature DB >> 15965665 |
Abstract
Cancer pain treatment should follow the recommendations of the World Health Organisation. Treatment should be with oral application, regular application times and following the analgesic step-ladder. Non-opioids such as dipyrone or non-steroids are used for slight to moderate pain, step-2 opioids such as tramadol or tilidine/naloxone for moderate pain and step-3 opioids such as morphine, oxycodone or hydromorphone for severe pain. Transdermal application of fentanyl or buprenorphine offer a non-invasive parenteral alternative for patients with stable pain syndromes. Cannabinoids such as tetrahydrocannabinol offer a valuable add-on option for cancer patients with refractory pain, spasticity, nausea or appetite loss.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15965665 DOI: 10.1007/s00108-005-1442-5
Source DB: PubMed Journal: Internist (Berl) ISSN: 0020-9554 Impact factor: 0.743